SS&C Technologies Holdings, Inc.

SS&C is the "software plumbing" of the asset-management and healthcare-admin industries — fund accounting (Geneva), portfolio accounting (Advent), fund administration (GlobeOp), transfer agency (DST/GIDS), RPA/automation (Blue Prism), secure data rooms (Intralinks), and pharmacy-claims adjudication (The Claims Engine). It runs as one reportable segment (FY2025 10-K Note 19) with revenue split by source: technology-enabled services (83%) and license/maintenance (17%).

• Balance sheet: cash $434.8M, gross debt $7,613.5M, net leverage 2.75×, net secured 1.70× (LTM EBITDA $2,610.4M).
• H1 2026 operating cash flow $716.4M (+11.1%). Q2 returned $499.2M to shareholders ($435.2M buyback of a record 6.4M shares + $64.0M dividend).
• Dividend raised $0.27→$0.30/quarter (≈1.4% yield, ~34% payout).
• FY2026 guidance raised: revenue $6,672–$6,832M; adj EPS $6.93–$7.25; organic +5.5% midpoint; EBITDA +9.3%; 40% EBITDA-margin goal in Q4 2026. Q3 guidance: rev $1,657–$1,697M, adj EPS $1.73–$1.79.
• Market: ~$19.5B market cap, P/E ~24, 52-wk range $61.40–$91.07, 96.9% institutional (BlackRock 7.17%).

• monetization model: Recurring software-enabled services (SaaS/cloud/outsourcing) + maintenance; smaller professional services and software license fees. [10-K § Business; § Revenue]
• revenue mix: FY2023 total $5,475.8M. Segments: Financial Services ~90.7% ($4,966.8M); Healthcare ~9.3% ($509.0M). By type: software-enabled services ~80%, maintenance ~10%, professional services ~7%, software licenses ~3%. [10-K § Segment/Revenue note]
• who pays: Enterprise financial-services and healthcare organizations; economic buyers are operations/technology/finance executives (CIO/COO/CFO) and fund/healthcare administrators. [10-K § Business]
• margin_value_capture: FY2023 gross margin ~64%; GAAP operating margin ~18%. Value accrues mainly in recurring software-enabled services/maintenance; services mix dilutes margin. [10-K § MD&A/Income statement]

• customer classes: Asset managers, hedge/private-equity fund managers, banks, wealth managers, insurers, healthcare providers/payers, Compliance & GRC Officers (for compliance/regulatory reporting).

Sources: SSNC FY2023 Form 10-K, Accession No. 0001402436-24-000008, sec.gov . Latest 10-Q not needed; 10-K covers these fields. Note: FY2023 is the latest 10-K in my knowledge cutoff; verify newer filings for updates.

SS&C Technologies Holdings, Inc. sells software and software-enabled services to the financial-services and healthcare industries. Its economic model is a mix of recurring software-enabled services, ratable maintenance, perpetual/term license, and professional-services revenue. The company markets itself as a global provider of mission-critical back-office and front-to-back-office technology. It monetizes through annual or multi-year subscription/SaaS contracts, transaction-based or asset-based fees in fund administration and healthcare administration, software licences with annual maintenance, and professional implementation/consulting services.

SS&C has historically operated as a single reportable segment, so the more useful primary-source revenue breakdown is by revenue type, as disclosed in the Form 10-K. The following table is the revenue mix I use for model calculations. Figures are from the issuer’s FY2023 Form 10-K and are tentative pending live re-resolution; verify against the EDGAR document before trading on them.

SS&C’s customer classes, as described in its filings, include:

• Alternative asset managers: hedge funds, private equity, private credit, funds of funds
• Institutional asset managers: pension funds, endowments, foundations, sovereign wealth managers
• Wealth management/RIA firms: registered investment advisers, independent broker-dealers
• Banks and capital-markets participants: broker-dealers, prime brokers, custodians, margin/lending businesses
• Insurance and financial-services firms: annuity carriers, reinsurers, retirement plan administrators
• Corporates and professional-services firms: M&A teams using Intralinks, treasury operations
• Healthcare payers and providers: health plans, managed-care organisations, third-party administrators

• FY2025 revenue $6,272.2M (+6.6% vs FY2024 $5,882.0M); FY2025 gross margin 48.2%, op margin 22.9%, net income $796.9M.
• Q2 2026 revenue $1,695.7M (+10.3%); GAAP operating income $417.1M (24.6% margin, +220 bps YoY); GAAP net income $234.8M (+29.9%); GAAP diluted EPS $0.97 (+34.7%).
• Adjusted (non-GAAP): revenue $1,696.9M, adj operating income $653.8M (38.5% margin), adj consolidated EBITDA $670.7M (39.5% margin), adj diluted EPS $1.76 (+18.1%).
• Adjusted organic revenue growth 7.6% — a multi-year high that refutes the "low-single-digit roll-up" bear thesis.

Digital Trust > Compliance & GRC > fund accounting / regulatory books as switching-cost software for asset managers

Next earnings (last reported 2026-07-23); AUM-linked processing volumes; ex-div 2026-09-01

1. Implied toll rate on administered assets: GlobeOp revenue $1.77B ÷ ~$2.9T alternative AUA ≈ 6.1 bps. The fee is a tiny fraction of the assets it administers but the function is non-discretionary for a fund.
2. Switching-cost floor: a fund administrator moving off Geneva/GlobeOp must re-migrate historical NAVs, positions, and investor ledgers and re-establish regulated/audited status. Even assuming a 20% competitive fee discount on $100B AUA (≈ $6.1M/yr saved), a migration cost conservatively modeled at $10M–$50M + 12–24 months of operational disruption implies a 2–8 year payback — economically irrational to switch for price alone. This is the quantitative constraint that keeps revenue sticky (83% recurring).
3. Cost of the moat vs moat defended (M&A roll-up): largest deals — DST $5.4B (2018), Advent $2.7B (2015), Blue Prism $1.6B (2022), Intralinks $1.0B (2018) — plus ~$7.6B gross debt (net leverage 2.75×) defend $2.61B LTM EBITDA → ~4–7× EBITDA cumulative acquisition cost. The ongoing cost is visible in the GAAP/adj gap: GAAP EPS $0.97 vs adj $1.76 → ~45% of adjusted EPS is amortization of acquired intangibles.

Q2 GAAP revenue +$158.9M YoY. 10-Q MD&A splits that into +$117.6M organic (74% of the print) + $35.9M acquisitions (Calastone Oct-2025, Curo Nov-2025, FPS Trust Feb-2025) + $5.4M FX. So the 10.3% headline is not a roll-up print: three-quarters of the beat is organic, concentrated in GlobeOp / Wealth / GIDS.

EX-99.2 unit organic rates (on FY2025 revenue bases):

Core fund-admin + wealth + GIDS ≈ $4.88B / $6.28B = 78% of the FY2025 base and all three are running mid/high-single-digit organic. The two contracting units are 13% of the base and subtract ~$14M annualized — not thesis-breaking, but they cap a "platform AI" narrative: Blue Prism (the AI/automation vehicle) is the unit that went negative.

GlobeOp FY2025 $1.77B ÷ $2.9T alternative AUA (10-K floor) = 6.1 bps of AUA as the implied administration toll.

On a $100B AUA book that is 6.1 bps × $100B = $61.0M/year, not the $6.1M the 2026-08-29 note used (that note applied 6.1 bps to $100B as if it were 0.61 bps). A 20% competitive fee cut would save $12.2M/year. A $10–50M one-time migration then pays back in 0.8–4.1 years on fees alone — i.e. fee-discount switching is economically rational. The 08-29 "2–8 year payback / irrational to switch" claim does not survive the arithmetic.

What still locks the book is the unpriced operational risk, modeled as a 3-phase admin-platform switch on that $100B book:

Payback vs a 20% fee save ($12.2M/yr): 9–13 years once parallel-run cash is counted — longer than a typical COO/CFO tenure, which restores the lock. The moat is parallel-run + NAV-error option value, not the 6.1 bp toll itself. Sensitivity: if AUA is $3.06T (secondary slide print, not extracted from EX-99.2 text) the bps toll falls to 5.8 bps and the $100B fee becomes $58M — same conclusion.

• Balance-sheet: goodwill $9,930M + net intangibles $3,874M = $13.80B = 67.0% of $20.61B assets (10-Q 2026-06-30).
• P&L: Q2 amortization $163.3M is 38.4% of adjusted net income $425.6M; GAAP EPS $0.97 is 45% below adj. EPS $1.76 (EX-99.1 Note 4).
• Cash cost of defense this year: H1 buybacks $605.7M + H1 dividends $129.3M = $735M returned, against H1 OCF $716.4M — >100% of H1 OCF went out the door (EX-99.1: "Year to date, we returned 100 percent of allocated capital to shareholders"). Net leverage still 2.75×.
• R&D $132.3M / quarter = 7.8% of revenue is the ongoing cost of keeping Geneva/Advent/Black Diamond current vs Broadridge / State Street Alpha / Addepar / Orion. Black Diamond AI is that R&D showing up as a product; attach revenue is undisclosed (unknown).

Read: the DT-5 book-of-record is real and cash-generative (39.5% adj. EBITDA, >95% retention), but it was purchased (DST, Advent, GlobeOp, Blue Prism, Calastone) and is serviced with 2.75× leverage plus a 38% amortization drag. STRONG PROXY is the ceiling; DIRECT BOTTLENECK would require a sole-source regulated rail SS&C does not have.

SS&C's PR (BusinessWire, 2026-09-10): Black Diamond AI is Assist (in-platform agentic nav) + Insights (Relationship / Reports / Planning / Trades summaries) + an MCP server so advisors can pull Black Diamond data into "their AI enterprise platform of choice," all gated by SS&C AI Gateway. Named users: Fiduciary Alliance (CEO Brian Boughner) and HB Wealth (Sean Hendler). No price, no attach-rate, no ACV, no 8-K — i.e. non-material to reported revenue on day one.

Thesis mapping: this is the product-layer defense of the Wealth & Investment Technologies rebound (EX-99.2: −0.4% Q1 → +9.8% Q2 on a $1.51B base). MCP + AI Gateway is a switching-cost thickener (more workflow surface on the same ledger), not a new scarce model. Hyperscalers (Microsoft Copilot, Google Gemini for Workspace) remain the substitute at the assistant layer; they do not replace the wealth ledger / reconciliation / performance engine. Toll-road Q3 (hyperscaler) stays PASS (3/3).